DNAI SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving ProNAi ...
December 21 2016 - 9:58AM
Business Wire
The Law Offices of Vincent Wong announce that a class action
lawsuit has been commenced in the USDC for the Southern District of
New York on behalf of investors who purchased ProNAi Therapeutics,
Inc. (NASDAQ: DNAI) securities between July 15, 2015 and June 6,
2016.
Click here to learn about the case:
http://www.wongesq.com/pslra/pronai-therapeutics. There is
no cost or obligation to you.
According to the complaint, throughout the Class Period, ProNAi
made materially false and misleading statements about the potential
and efficacy of its drug product candidate PNT2258 in the company’s
public filings, which caused ProNAi’s stock price to be
artificially inflated throughout the Class Period, thus harming
investors.
On June 6, 2016, ProNAi revealed that the Phase 2 clinical
trials of PNT2258 failed to produce sufficient efficacy results to
justify continued clinical development of the drug and, thus,
ProNAi was suspending clinical development of PNT2258. Following
this news, shares of ProNAi fell more than 67 percent.
If you suffered a loss in ProNAi you have until January 9, 2017
to request that the Court appoint you as lead plaintiff. Your
ability to share in any recovery doesn’t require that you serve as
a lead plaintiff. To obtain additional information, contact Vincent
Wong, Esq. either via email vw@wongesq.com, by telephone at
212.425.1140, or visit
http://www.wongesq.com/pslra/pronai-therapeutics.
Vincent Wong, Esq. is an experienced attorney that has
represented investors in securities litigations involving financial
fraud and violations of shareholder rights. Attorney advertising.
Prior results do not guarantee similar outcomes.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161221005476/en/
Law Offices of Vincent WongVincent Wong, Esq., 212-425-1140Fax.
866-699-3880E-Mail: vw@wongesq.com
Sierra Oncology (NASDAQ:SRRA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sierra Oncology (NASDAQ:SRRA)
Historical Stock Chart
From Apr 2023 to Apr 2024